Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06753045 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Health Electronic Assessment of Risks and Trends Using Biometric Equipment and Technology

Study acronym: HEARTBEAT
StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 4 more changesShow less
    • Final enrollment: 1500 participants (planned 10000)
    • Primary and study completion moved earlier from Oct 2027 to Jul 2027
    • Eligibility criteria expanded, about 13 words
    • Site details revised at 3 of 3 sites
  2. Site contacts updated at 3 of 3 sitesv3
  3. Primary endpoints revised (2)v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Tulane University
47 trials monitored
See 8 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Diabetes
5,087 trials monitored
See 222 trials at risk
Heart Failure
1,995 trials monitored
See 111 trials at risk
and 3 more diseases
This is a phase 0, non-interventional, longitudinal, electronic data capture (EDC) study to facilitate the HEARTBEAT Study project has set out to explore the potential use of smartwatches in collecting and analyzing biometric data to improve the detection, identification, and understanding of cardiovascular diseases and related conditions by SAMSUNG and Tulane. The study will include up to ten thousand adult subjects tasked with wearing a smartwatch to collect digital biomarker data over a 1 year period. Concurrent to smartwatch data collection, subjects will be instructed to complete questionnaires via the Huma Decentralized Clinical Trials (HUMADCT) platform. There are no investigational drugs or interventions administered as part of this study.
Trial Details
NCT Number NCT06753045
Lead Sponsor Tulane University
Collaborators: Samsung Electronics
Conditions
(from sponsor)		 Heart Diseases
Related terms Arrhythmias, Cardiac, Atrial Fibrillation, Coronary Artery Disease, Diabetes Mellitus, Heart Diseases, Heart Failure, Renal Insufficiency, Chronic
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov